These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8971863

  • 1. Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPET.
    Bornebroek M, Verzijlbergen JF, Haan J, Van Scheyen EJ, Verhoeff NP, Pauwels EK, Roos RA.
    Nucl Med Commun; 1996 Nov; 17(11):929-33. PubMed ID: 8971863
    [Abstract] [Full Text] [Related]

  • 2. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
    Maulin L, Hachulla E, Deveaux M, Janin A, Wechsler B, Godeau P, Rousset H, Barrier JH, Hatron PY, Devulder B, Huglo D, Marchandise X.
    QJM; 1997 Jan; 90(1):45-50. PubMed ID: 9093588
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
    Hachulla E, Maulin L, Deveaux M, Facon T, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Hatron PY, Huglo D, Devulder B, Marchandise X.
    Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN, Lavender JP, Pepys MB.
    N Engl J Med; 1990 Aug 23; 323(8):508-13. PubMed ID: 2377176
    [Abstract] [Full Text] [Related]

  • 9. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
    Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE, Pugh CW, Winearls CG, Oliver DO, Pepys MB.
    Lancet; 1991 Aug 10; 338(8763):335-9. PubMed ID: 1677697
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recurrent hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy.
    van Etten ES, Gurol ME, van der Grond J, Haan J, Viswanathan A, Schwab KM, Ayres AM, Algra A, Rosand J, van Buchem MA, Terwindt GM, Greenberg SM, Wermer MJ.
    Neurology; 2016 Oct 04; 87(14):1482-1487. PubMed ID: 27590282
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
    Hazenberg BP, van Rijswijk MH, Lub-de Hooge MN, Vellenga E, Haagsma EB, Posthumus MD, Jager PL.
    J Nucl Med; 2007 Jun 04; 48(6):865-72. PubMed ID: 17504868
    [Abstract] [Full Text] [Related]

  • 16. Scintigraphy with 123I-serum amyloid P component in Alzheimer disease.
    Lovat LB, O'Brien AA, Armstrong SF, Madhoo S, Bulpitt CJ, Rossor MN, Pepys MB, Hawkins PN.
    Alzheimer Dis Assoc Disord; 1998 Sep 04; 12(3):208-10. PubMed ID: 9772025
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component.
    Hawkins PN, Myers MJ, Lavender JP, Pepys MB.
    Lancet; 1988 Jun 25; 1(8600):1413-8. PubMed ID: 2898580
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.